logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong Stock Movement | Livzon Pharmaceutical (01513.HK) rose nearly 4% before noon; its investee company Mao Haizi doxycycline oral paste recently approved for marketing

date
23/09/2026
Zhito Finance APP has learned that Livzon Pharmaceutical (01513.HK) rose nearly 4% before noon, up 3.67% as of press time, at HK$21.46, with a turnover of HK$17.8948 million.
Latest
2 m ago
China Merchants Securities International: Maintains target price of HK$32.5 and "Overweight" rating on Abbisko-B (02256.HK), believes the company is significantly undervalued by the market
9 m ago
HK Stock Movement | RIGOL Technologies (00537.HK) Surges Over 25% Intraday as AI Computing Infrastructure Drives Accelerated Upgrade of High-Speed Interconnects, Vector Network Analyzers Expected to See Opportunities
12 m ago
Meta Muse Sparks AI Agent Frenzy! US Stock Market Landscape Set for Reshaping as Winners and Losers May Emerge
14 m ago
HK Stock Movement | Andeli Juice (02218.HK) Rises Over 10% as Executive Director Wang Meng Continues to Increase Shareholding in the Company, Having Previously Gained Control of Yongqiang Technology
14 m ago
Seaport Research Partners: Initiates coverage on Marvell Technology (MRVL.O) with a Buy rating; price target $270.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.